Short-term Top 10 — Health Care

Catalysts 90th: analysts have raised their average price target by 12.2% since the prior reading; trend 84th: a "golden cross" — its 50-day average is above its 200-day; weakest is momentum 56th: MACD momentum is negative.

Trend 95th: the price is 21% above the average price paid over the period covered, so the typical buyer over that stretch is showing a gain; volume and participation 69th: trading volume is about normal versus its 30-day average; weakest is setup 58th: no Elliott-wave labelling currently fits its swings.

Catalysts 82nd: analysts have raised their average price target by 13.5% since the prior reading; trend 74th: a strong uptrend, with buyers in control; weakest is setup 42nd: no Elliott-wave labelling currently fits its swings.

Trend 76th: a "golden cross" — its 50-day average is above its 200-day; volume and participation 66th: trading volume is about normal versus its 30-day average; weakest is setup 49th: no fresh 20-day breakout up or down.

Volume and participation 77th: trading volume is about normal versus its 30-day average; trend 71st: a strong uptrend, with buyers in control; weakest is setup 41st: day-to-day price swings are wider than usual versus its own recent 6-month history (wider than about 74% of it).

Volume and participation 70th: it gapped 12.5% above the previous close and has not traded back through the level it left behind — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed; trend 63rd: a strong uptrend, with buyers in control; weakest is setup 42nd: day-to-day price swings are unusually wide versus its own recent history (wider than about 87% of the past ~6 months).

Volume and participation 99th: trading volume is running unusually high — about 2.7× its 30-day average, a sign of heightened interest; trend 94th: the price is 35% above the average price paid over the period covered, so the typical buyer over that stretch is showing a gain; weakest is setup 35th: over the past year its closes ranged, and it has retraced essentially none of its move over the past year — 0% of it. Its score is docked 10 points for overextended (RSI above 75 or stochastic above 90).

Volume and participation 79th: trading volume is about normal versus its 30-day average; trend 73rd: it is trading 14.2% above its 50-day average, the short-term trend line; weakest is setup 39th: over the past year its closes ranged, and it has retraced only a small part of its move over the past year — 6% of it. Its score is docked 10 points for overextended (RSI above 75 or stochastic above 90).

Trend 80th: the price is 32% above the average price paid over the period covered, so the typical buyer over that stretch is showing a gain; volume and participation 57th: trading volume is about normal versus its 30-day average; weakest is catalysts 43rd: the analyst consensus rating has softened toward "sell" since the prior reading. Its score is docked 10 points for overextended (RSI above 75 or stochastic above 90).

Volume and participation 87th: trading volume is about normal versus its 30-day average; trend 75th: the price is 15% above the average price paid over the period covered, so the typical buyer over that stretch is showing a gain; weakest is catalysts 20th: the analyst consensus rating has softened toward "sell" since the prior reading. Its score is docked 10 points for overextended (RSI above 75 or stochastic above 90).